DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Medtech (369)

Trauma Devices and Reconstructive Joint Implants | China | 2014 | Market Analysis

China will continue to exhibit strong growth and will be the focus of market expansion from large multinational orthopedic device companies, as well as some of the most successful Chinese medical device companies

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for trauma and reconstructive implant devices in China across a 10-year period.

Questions Answered in This Report:

  • Procedure volume growth is significantly higher in China than in the US or Europe and is the primary driver of trauma device and reconstructive joint implant market expansion.

    What factors are driving this procedure growth and which product segments will be most impacted by them?

    How does the epidemiology of conditions such as osteoarthritis differ in China from in the US or Europe?

  • The Chinese trauma device and reconstructive joint implants market is characterized by large regional disparities.

    Where are the fastest-growing regional markets?

    What cities and hospitals perform the procedures?

    In what regions do domestic manufacturers have the strongest market presence?

  • Acquisitions have played a major role in shaping the competitive landscape in the Chinese market for trauma devices and reconstructive joint implants

    Which Chinese orthopedics companies have been acquired by multinationals in recent years?

    What other strategies are multinational manufacturers employing to gain a deeper foothold in the Chinese orthopedic device market?

Scope:

Geographies Covered: DRG's analysis uses the following breakdown of regions in China:

Country

China

Region

PLMs

East Coast

Central

Other Regions

Notes: PLMs include Beijing, Shanghai, and Tianjin. East coast includes Fujian, Guangdong, Jiangsu, Shandong, and Zhejiang. Central includes Anhui, Hebei, Henan, Hubei, Hunan, Jiangxi, and Shanxi. Other regions include Chongqing, Gansu, Guangxi, Guizhou, Hainan, Heilongjiang, Inner Mongolia, Jilin, Liaoning, Ningxia, Qinghai, Shaanxi, Sichuan, Tibet, Xinjiang, and Yunnan.

Procedures and Products Covered:

Product Type

Trauma Devices

Technique

Internal Fixation

Product Type

Plates and Screws

Product Feature*

Standard Locking

Standard Nonlocking

Anatomic

IM Nails

Product Type*

Cephalomedullary

Other**

External Fixation

Reconstructive Joint Implants

Anatomy

Hip

Product Type

Primary THA

Product Feature*

Cemented

Hybrid

Cementless

Partial Hip

Resurfacing

Revision

Knee

Product Type

Primary TKA

Product Feature*

Cemented

Hybrid

Cementless

Unicondylar

Patello-Femoral

Revision

Shoulder

Notes: *This segmentation is not provided for procedures and applies to the market breakdowns only. **Other includes tibial, femoral, humeral, radial, ulnar, fibular, hand, foot, and ankle IM nails.

Market Forecast Features: Based on primary research with industry professionals, DRG uses its proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 10-year period (2012–2022).

Competitive Analysis: DRG provides a detailed analysis of the competitive landscape and market shares for leading competitors.